Franco Meschi
Overview
Explore the profile of Franco Meschi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
565
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Castorani V, Favalli V, Rigamonti A, Frontino G, Di Tonno R, Morotti E, et al.
Acta Diabetol
. 2023 Aug;
60(12):1719-1726.
PMID: 37526745
Aims: The target of metabolic control (HbA1c < 7% or 53 mmol/mol) recommended by the ADA and ISPAD is attained by 30% of children with Type 1 Diabetes (T1D). Advances...
2.
Frontino G, Di Tonno R, Castorani V, Rigamonti A, Morotti E, Sandullo F, et al.
Front Endocrinol (Lausanne)
. 2022 Aug;
13:900325.
PMID: 35928892
Introduction: Despite the use of technology, recurrent diabetic ketoacidosis (DKA) prevention remains an unmet need in children and adolescents with T1D and may be accompanied by life-threatening acute complications. We...
3.
Frontino G, Raouf T, Canarutto D, Tirelli E, Di Tonno R, Rigamonti A, et al.
Front Pediatr
. 2021 Dec;
9:755365.
PMID: 34970515
Wolfram syndrome type 1 is a rare recessive monogenic form of insulin-dependent diabetes mellitus with progressive neurodegeneration, poor prognosis, and no cure. Based on preclinical evidence we hypothesized that liraglutide,...
4.
Vecchione A, Di Fonte R, Gerosa J, Jofra T, Cicalese M, Napoleone V, et al.
Clin Immunol
. 2019 Dec;
211:108319.
PMID: 31794865
Autoantibodies (AAbs) are a hallmark of Type 1 diabetes (T1D). Alterations in the frequency and phenotype of follicular helper (Tfh) T cells have been previously documented in patients with type...
5.
Frontino G, Meschi F, Bonfanti R, Rigamonti A, Battaglino R, Favalli V, et al.
Eur Endocrinol
. 2018 Oct;
9(1):6-11.
PMID: 30349603
The prevalence of diabetes is increasing. improved glucose control is fundamental to reduce both long-term micro- and macrovascular complications and short-term complications, such as diabetic ketoacidosis and severe hypoglycemia. Frequent...
6.
Frontino G, Meschi F, Rigamonti A, Favalli V, Bonura C, Bonfanti R
Diabetes Technol Ther
. 2016 Feb;
18(6):404.
PMID: 26914242
No abstract available.
7.
Bonura C, Frontino G, Rigamonti A, Battaglino R, Favalli V, Ferro G, et al.
Dermatoendocrinol
. 2014 Feb;
6(1):e27790.
PMID: 24575162
Introduction: Necrobiosis lipoidica (NL) is a rare chronic granulomatous dermatitis that usually appears in the lower extremities. It affects about 0.3-1.2% of diabetic patients, the majority of whom have type...
8.
Grasso V, Colombo C, Favalli V, Galderisi A, Rabbone I, Gombos S, et al.
Acta Diabetol
. 2013 Jul;
50(6):951-7.
PMID: 23824322
Biallelic insulin receptor (INSR) gene mutations cause congenital syndromes of severe insulin resistance (SIR) known as Donohue syndrome (DS) and Rabson-Mendenhall syndrome (RMS). At presentation, DS and RMS are difficult...
9.
Valle A, Giamporcaro G, Scavini M, Stabilini A, Grogan P, Bianconi E, et al.
Diabetes
. 2013 Jan;
62(6):2072-7.
PMID: 23349491
Human type 1 diabetes (T1D) is an autoimmune disease associated with major histocompatibility complex polymorphisms, β-cell autoantibodies, and autoreactive T cells. However, there is increasing evidence that innate cells may...
10.
Frontino G, Bonfanti R, Scaramuzza A, Rabbone I, Meschi F, Rigamonti A, et al.
Diabetes Technol Ther
. 2012 Jun;
14(9):762-4.
PMID: 22694194
Background: Efficacy and feasibility of sensor-augmented pump (SAP) therapy were evaluated in very young children with type 1 diabetes (T1D). Subjects And Methods: SAP (Dexcom [San Diego, CA] Seven Plus™...